{
  "nct_id": "WO44263 UW 23-384",
  "age": "Adults",
  "cancer_center_accrual_goal_upper": 0,
  "data_table4": "Interventional",
  "drug_list": {
    "drug": [
      {
        "drug_name": "Inavolisib"
      }
    ]
  },
  "long_title": "A phase III, multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of Inavolisib in combination with Phesgo versus placebo in combination with Phesgo as maintenance therapy after first line induction therapy in participants with PIK3CA‑mutated HER2‑positive locally advanced or metastatic breast cancer (INAVO122)",
  "management_group_list": {
    "management_group": [
      {
        "is_primary": "Y",
        "management_group_name": "HKUMed"
      }
    ]
  },
  "oncology_group_list": {
    "oncology_group": [
      {
        "group_name": "Group 1",
        "is_primary": "N"
      }
    ]
  },
  "phase": "3",
  "principal_investigator": "Dr Wendy CHAN",
  "principal_investigator_institution": "HKU",
  "program_area_list": {
    "program_area": [
      {
        "is_primary": "Y",
        "program_area_name": "Program 1"
      }
    ]
  },
  "protocol_id": null,
  "protocol_no": "",
  "protocol_target_accrual": 0,
  "protocol_type": "",
  "prior_treatment_requirements": [
    "HER2+ advanced breast cancer with PIK3CA‑mutation",
    "Achieved partial response after 4-8 cycles of taxane-based chemotherapy with trastuzumab+pertuzumab"
  ],
  "short_title": "Study evaluating the efficacy and safety of Inavolisib in combination with Phesgo in participants with breast cancer",
  "site_list": {
    "site": []
  },
  "sponsor_list": {
    "sponsor": []
  },
  "staff_list": {
    "protocol_staff": []
  },
  "status": "open to accrual",
  "summary": "",
  "treatment_list": {
    "step": [
      {
        "arm": [
          {
            "arm_code": "Arm A",
            "arm_internal_id": 1111,
            "arm_description": "Treatment with Inavolisib in combination with Phesgo",
            "arm_suspended": "N"
          },
          {
            "arm_code": "Arm B",
            "arm_internal_id": 2222,
            "arm_description": "Placebo in combination with Phesgo",
            "arm_suspended": "N"
          }
        ],
        "step_code": "1",
        "step_type": "Registration",
        "step_internal_id": 1111,
        "match": [
          {
            "and": [
              {
                "clinical": {
                  "oncotree_primary_diagnosis": "Invasive Breast Carcinoma",
                  "her2_status": "Positive"
                }
              },
              {
                "genomic": {
                  "hugo_symbol": "PIK3CA",
                  "variant_category": "Mutation"
                }
              }
            ]
          }
        ]
      }
    ]
  }
}